Synthetic pineal-derived tetrapeptide / AEDG peptide
Epithalon is a synthetic four-amino-acid peptide researched for telomere biology, circadian signaling, and longevity. The interesting results are mostly from cultured cells, flies, rodents, and one limited human biomarker report—not controlled proof that it slows aging or extends human life.
Built by the community
Every structured report adds useful context about research setup, outcomes, and unwanted effects as the community dataset grows.
Publicly anonymous by default. Your account keeps reports editable and helps reduce duplicate submissions.Research at a glance
Depth and confidence summarize the research record—not effectiveness, safety, or a recommendation.
The direct record includes cell and animal studies plus one limited human circadian-biomarker report with essential protocol details missing.
Research depth describes how large and mature the overall record is. It does not tell you whether the results were positive.
No robust controlled human trial demonstrates longer life, better sleep, telomere benefit, disease prevention, or route-specific safety.
Confidence describes how reliable and consistent the conclusions are. It can be high for one outcome and low for another.
The strongest evidence type shows what the best-supported conclusions are actually based on.
Human findings are more directly relevant than animal or laboratory results, but they still apply only to the populations and outcomes studied.
Route-specific record
These are exposures used in cited research for a specific route and population—not a suggested amount.
Half-life describes how long it takes the measured amount in the body to fall by half. It is not a dosing recommendation.
Evidence can change by administration method. Findings from one route should not automatically be applied to another.
Evidence boundary: The report described melatonin-metabolite and circadian-gene changes, not sleep improvement, telomere lengthening, slower aging, longer life, or a usable protocol. Amounts shown describe cited research exposure—not a dosage recommendation.
Practical starting point
Common goals and questions—not recommendations or promises of benefit.
The overview, studies, and source ledger below explain what supports each label—and where the evidence stops.
The short version
Epithalon is a synthetic four-amino-acid peptide researched for telomere biology, circadian signaling, and longevity. The interesting results are mostly from cultured cells, flies, rodents, and one limited human biomarker report—not controlled proof that it slows aging or extends human life.
Evidence reviewed through July 25, 2026. Synthetic Epithalon/Epitalon is kept separate from the bovine pineal extract Epithalamin, and human, cell, animal, and mechanistic findings are labeled separately.
What the evidence says
One limited human circadian-biomarker report with essential design details missing from the indexed abstract
This is the strongest supported conclusion in the current human evidence—not a summary of every claim made about the compound.
Whether any laboratory or animal signal translates into clinically meaningful human benefit, and the short- and long-term safety of repeated human exposure
Keeping the main uncertainty visible prevents an early or promising finding from looking more settled than it is.
The evidence story
Importance shows how much an item changes the evidence story. Quality shows how much confidence the design deserves. A strong negative study can score highly on both.
Importance and quality answer different questions. A rigorous study can be highly important even when it challenges a popular claim.
Telomere length increased in normal and cancer cell lines. Normal cells showed telomerase-related changes, while cancer cells showed ALT-pathway activation.
Epitalon improved closure and several oxidative-stress and fibrosis markers in the cell model.
Neurogenic marker expression increased in cultured stem cells, and modelling suggested possible histone interactions.
The abstract reports a 1.7-fold increase in urinary 6-sulfatoxymelatonin, lower Clock and Csnk1e hyperexpression, and higher Cry2 expression.
The paper reported telomerase expression and activity plus telomere elongation in cultured fibroblasts.
Administration and handling
No approved human dose, route, frequency, cycle, or conversion was identified. The limited human circadian paper's indexed abstract does not disclose route, schedule, or dose. Published cell concentrations and fly, rat, or mouse exposure schedules describe those experiments only and must not be converted into self-use instructions.
No FDA-approved Epithalon product label, validated consumer reconstitution procedure, storage condition, sterility standard, or beyond-use date was identified. FDA notes possible aggregation, immunogenicity, and peptide-related impurity concerns for compounded Epitalon. Powder, acetate, solution, and other seller-labeled forms cannot be assumed equivalent, sterile, stable, or correctly identified.
Primary-source ledger
2025-09-04 · PMID 40908429 · DOI 10.1007/s10522-025-10315-x
2025-06-10 · PMID 40493162 · DOI 10.1007/s12015-025-10911-x
2025-03-17 · PMID 40141333 · DOI 10.3390/ijms26062691
2020-01-30 · PMID 32019204 · DOI 10.3390/molecules25030609
2020-01-01 · PMID 33280326
2007-01-01 · PMID 17317455 · DOI 10.1016/j.archger.2007.01.029
2003-06-01 · PMID 12937682 · DOI 10.1023/A:1025493705728
2002-08-01 · PMID 12459848 · DOI 10.1023/A:1021104819170
2000-12-01 · PMID 11087911 · DOI 10.1016/S0047-6374(00)00217-7